Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the NIIH, announced…
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…
On Jun. 17, 2020, DNA from uterine cells of women with endometriosis has different chemical modifications, compared to…
On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
On May 11, 2020, Regeneron and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado…
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
On May 6, 2020, the U.S. Dept. of Agriculture (USDA) announced that a new freeze-resistant Trichinella species had…
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
On Apr. 28, 2020, INOVIO announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800…
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase…
On Apr. 27, 2020, Ichor announced that its TriGrid Delivery System is being utilized for delivery in non-human…
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
On Apr. 9, 2020, Codex DNA announced a newly developed and released suite of products and services designed…
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
On Mar. 23 2020, The Priestley Medal was awarded to JoAnne Stubbe by the American Chemical Society “to…
On Mar. 18, 2020, Entos Pharmaceuticals announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections….
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…